Formulations for trans-tympanic antibiotic delivery

Biomaterials

Volumn 34, Issue 4, 2013, Pages 1281-1288

  Khoo, Xiaojuan ^c,d   Simons, Emmanuel J ^a,d   Chiang, Homer H ^d   Hickey, Julia M ^d   Sabharwal, Vishakha ^e   Pelton, Stephen I ^e   Rosowski, John J ^a,b   Langer, Robert ^a,c   Kohane, Daniel S ^a,d  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c USA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

Controlled drug release; Drug delivery; Hydrogels; Infection

Indexed keywords

AUDITORY THRESHOLDS; BUPIVACAINE; CIPROFLOXACIN; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; IN-VIVO; INFECTION; MIDDLE EARS; MINIMAL EFFECTS; OTITIS MEDIA; PERMEATION ENHANCERS; POLOXAMER; SINGLE-DOSE; SODIUM DODECYL SULFATE; TISSUE RESPONSE; TYMPANIC MEMBRANES;

ANTIBIOTICS; DRUG DELIVERY; SODIUM; SODIUM SULFATE; TISSUE;

HYDROGELS;

BUPIVACAINE; CIPROFLOXACIN; DODECYL SULFATE SODIUM; LIMONENE; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; EARDRUM; FEMALE; HYDROGEL; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSTYMPANIC DRUG ADMINISTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CHINCHILLA; CIPROFLOXACIN; DRUG COMPOUNDING; MALE; NANOCAPSULES; OTITIS MEDIA; TYMPANIC MEMBRANE;

EID: 84870327736     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.025     Document Type: Article

References (61)

1. Berman S. Otitis media in children. N Engl J Med 1995, 332(23):1560-1565.
2. Freid V.M., Makuc D.M., Rooks R.N. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat 1998, 13(137):1-23.
3. Faden H., Duffy L., Boeve M. Otitis media: back to basics. Pediatr Infect Dis J 1998, 17(12):1105-1112.
4. Bluestone C.D., Klein J.O. Otitis media in infants and children 2007, BC Decker, Inc, Hamilton.
5. Pichichero M.E. Acute otitis media: part II. Treatment in an era of increasing antibiotic resistance. Am Fam Physician 2000, 61(8):2410-2416.
6. Koulich E., Roland P.S., Pawlowski K.S. Comparison of systemic and otic administration of ofloxacin. Laryngoscope 2010, 120(10):2083-2088.
7. Prausnitz M.R., Mitragotri S., Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004, 3(2):115-124.
8. Prausnitz M.R., Langer R. Transdermal drug delivery. Nat Biotechnol 2008, 26(11):1261-1268.
9. Walker R.B., Smith E.W. The role of percutaneous penetration enhancers. Adv Drug Deliv Rev 1996, 18:295-301.
10. Bauerova K., Matusova D., Kassai Z. Chemical enhancers for transdermal drug transport. Eur J Drug Metab Pharmacokinet 2001, 26(1-2):85-94.
11. Karande P., Jain A., Ergun K., Kispersky V., Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A 2005, 102(13):4688-4693.
12. Bronaugh R.L., Maibach H.I. Percutaneous absorption: drugs-cosmetics-mechanisms-methodology 1999, Marcel Dekker, New York. 3rd, rev. and expanded. ed.
13. Williams A. Transdermal and topical drug delivery: from theory to clinical practice 2003, Pharmaceutical Press, London.
14. Guy R.H., Hadgraft J. Transdermal drug delivery 2003, Informa HealthCare.
15. Kabanov A.V., Batrakova E.V., Alakhov V.Y. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002, 82(2-3):189-212.
16. Moghimi S.M., Hunter A.C. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol 2000, 18(10):412-420.
17. Ruel-Gariépy E., Leroux J.-C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur J Pharm Biopharm 2004, 58(2):409-426.
18. Wall G.M., Stroman D.W., Roland P.S., Dohar J. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections. Pediatr Infect Dis J 2009, 28(2):141.
19. Takács-Novák K., Józan M., Hermecz I., Szász G. Lipophilicity of antibacterial fluoroquinolones. Int J Pharm 1992, 79(1-3):89-96.
20. Schmolka I.R. Artificial skin I. Preparation and properties of Pluronic F-127 gels for treatment of burns. J Biomed Mater Res A 1972, 6(6):571-582.
21. Yun M.O., Choi H.G., Jung J.H., Kim C.K. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement. Int J Pharm 1999, 189(2):137-145.
22. Tang H., Mitragotri S., Blankschtein D., Langer R. Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. J Pharm Sci 2001, 90(5):545-568.
23. Kasting G.B., Bowman L.A. Electrical analysis of fresh, excised human skin: a comparison with frozen skin. Pharm Res 1990, 7(11):1141-1146.
24. Kasting G.B., Bowman L.A. DC electrical properties of frozen, excised human skin. Pharm Res 1990, 7(2):134-143.
25. El-Kattan A.F., Asbill C.S., Kim N., Michniak B.B. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations. Drug Deliv 2000, 7(3):147-153.
26. Gorukanti S.R., Li L., Kim K.H. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation. Int J Pharm 1999, 192(2):159-172.
27. Gwak H.S., Kim S.U., Chun I.K. Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch Pharm Res 2002, 25(3):392-396.
28. Gwak H.S., Oh I.S., Chun I.K. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers. Drug Dev Ind Pharm 2004, 30(2):187-194.
29. Huang Y.B., Fang J.Y., Hung C.H., Wu P.C., Tsai Y.H. Cyclic monoterpene extract from cardamom oil as a skin permeation enhancer for indomethacin: in vitro and in vivo studies. Biol Pharm Bull 1999, 22(6):642-646.
30. Kim D.D., Chien Y.W. Transdermal delivery of zalcitabine: in vitro skin permeation study. AIDS 1995, 9(12):1331-1336.
31. Mura P., Faucci M.T., Bramanti G., Corti P. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 2000, 9(4):365-372.
32. Williams A.C., Barry B.W. Penetration enhancers. Adv Drug Deliv Rev 2004, 56(5):603-618.
33. Hoare T.R., Kohane D.S. Hydrogels in drug delivery: progress and challenges. Polymer 2008, 49(8):1993-2007.
34. Ricci E.J., Lunardi L.O., Nanclares D.M., Marchetti J.M. Sustained release of lidocaine from poloxamer 407 gels. Int J Pharm 2005, 288(2):235-244.
35. Langer R. New methods of drug delivery. Science 1990, 249(4976):1527.
36. Gilbert J.C., Hadgraft J., Bye A., Brookes L.G. Drug release from pluronic F-127 gels. Int J Pharm 1986, 32(2-3):223-228.
37. Hudson S.P., Langer R., Fink G.R., Kohane D.S. Injectable in situ cross-linking hydrogels for local antifungal therapy. Biomaterials 2010, 31(6):1444-1452.
38. Ruel-Gariépy E., Shive M., Bichara A., Berrada M., Le Garrec D., Chenite A., et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 2004, 57(1):53-63.
39. Hoffer M.E., Balough B.J., Kopke R.D., Henderson J., Decicco M., Wester D.C., et al. Morphologic changes in the inner ear of chinchilla laniger after middle ear administration of gentamicin in a sustained-release vehicle. Otolaryngol Head Neck Surg 1999, 120(5):643.
40. Sheppard W.M., Wanamaker H.H., Pack A., Yamamoto S., Slepecky N. Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity. Otolaryngol Head Neck Surg 2004, 131(6):890-896.
41. Uhde G. The problem of permeability and anesthesia of the tympanic membrane. Arch Otolaryngol Head Neck Surg 1957, 66(4):391-407.
42. Doyle W.J., Alper C.M., Seroky J.T., Karnavas W.J. Exchange rates of gases across the tympanic membrane in rhesus monkeys. Acta Otolaryngol 1998, 118(4):567-573.
43. Hoffman R.A., Li C.L. Tetracaine topical anesthesia for myringotomy. Laryngoscope 2001, 111(9):1636-1638.
44. Karande P., Jain A., Mitragotri S. Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J Control Release 2006, 115(1):85-93.
45. Karande P., Jain A., Mitragotri S. Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers. J Control Release 2006, 110(2):307-313.
46. Lopez R.F.V., Seto J.E., Blankschtein D., Langer R. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials 2011, 32(3):933-941.
47. Bagul A., Taha R., Metcalfe M., Brook N., Nicholson M. Pre-incision infiltration of local anesthetic reduces postoperative pain with no effects on bruising and wound cosmesis after thyroid surgery. Thyroid 2005, 15(11):1245-1248.
48. Tsang M., Guy R.H. Effect of aqueous cream BP on human stratum corneum in vivo. Br J Dermatol 2010, 163(5):954-958.
49. Karande P., Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta 2009, 1788(11):2362-2373.
50. Karande P., Arora A., Pham T.K., Stevens D., Wojicki A., Mitragotri S. Transcutaneous immunization using common chemicals. J Control Release 2009, 138(2):134-140.
51. Chen-Chow P.C., Frank S.G. In vitro release of lidocaine from Pluronic F-127 gels. Int J Pharm 1981, 8(2):89-99.
52. Veyries M.L., Couarraze G., Geiger S., Agnely F., Massias L., Kunzli B., et al. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm 1999, 192(2):183-193.
53. Yong C.S., Choi J.S., Quan Q.Z., Rhee J.D., Kim C.K., Lim S.J., et al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm 2001, 226(1-2):195-205.
54. Juhasz J., Lenaerts V., Raymond P., Ong H. Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels. Biomaterials 1989, 10(4):265-268.
55. Liu T., Chu B. Formation of homogeneous gel-like phases by mixed triblock copolymer micelles in aqueous solution: FCC to BCC phase transition. J Appl Cryst 2000, 33:727-730.
56. Vadnere M., Amidon G., Lindenbaum S., Haslam J.L. Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm 1984, 22(2-3):207-218.
57. Gilbert J.C., Richardson J.L., Davies M.C., Palin K.J., Hadgraft J. The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Control Release 1987, 5(2):113-118.
58. Ikiz A.ö., Serbetçioglu B., Güneri E.A., Sütay S., Ceryan K. Investigation of topical ciprofloxacin ototoxicity in guinea pigs. Acta Otolaryngol 1998, 118(6):808-812.
59. Brownlee R.E., Hulka G.F., Prazma J., Pillsbury H.C. Ciprofloxacin: use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992, 118(4):392.
60. Daniel H.J., Fulghum R.S., Brinn J.E., Barrett K.A. Comparative anatomy of eustachian tube and middle ear cavity in animal models for otitis media. Ann Otol Rhinol Laryngol 1982, 91(1 Pt 1):82-89.
61. Vrettakos P.A., Dear S.P., Saunders J.C. Middle ear structure in the chinchilla: a quantitative study. Am J Otolaryngol 1988, 9(2):58-67.